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Background: Leprosy-related disability is a challenge to public health, and social and rehabilitation services in
endemic countries. Disability is more than a mere physical dysfunction, and includes activity limitations,
stigma, discrimination, and social participation restrictions. We assessed the extent of disability and its
determinants among persons with leprosy-related disabilities after release from multi drug treatment.
Methods: We conducted a survey on disability among persons affected by leprosy in Indonesia, using a Rapid
Disability Appraisal toolkit based on the International Classification of Functioning, Disability and Health.
The toolkit included the Screening of Activity Limitation and Safety Awareness (SALSA) scale, Participation
Scale, Jacoby Stigma Scale (anticipated stigma), Explanatory Model Interview Catalogue (EMIC) stigma scale
and Discrimination assessment. Community members were interviewed using a community version of the
stigma scale. Multivariate linear regression was done to identify factors associated with social participation.
Results: Overall 1,358 persons with leprosy-related disability (PLD) and 931 community members were
included. Seventy-seven percent of PLD had physical impairments. Impairment status deteriorated significantly
after release from treatment (from 59% to 77%). Around 60% of people reported activity limitations and
participation restrictions and 36% anticipated stigma. As for participation restrictions and stigma, shame,
problems related to marriage and difficulties in employment were the most frequently reported problems. Major
determinants of participation were severity of impairment and level of education, activity and stigma. Reported
severity of community stigma correlated with severity of participation restrictions in the same districts.
Discussion: The majority of respondents reported problems in all components of disability. The reported
physical impairment after release from treatment justifies ongoing monitoring to facilitate early prevention.
Stigma was a major determinant of social participation, and therefore disability. Stigma reduction activities and
socio-economic rehabilitation are urgently needed in addition to strategies to reduce the development of further
physical impairment after release from treatment.
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A
bout 15% of the world’s population has some
form of disability (1). Disability is a difficulty in
functioning at the body, person, or societal levels,
in one or more life domains, as experienced by an
individual with a health condition in interaction with
contextual factors (2). Several dimensions of disability
are recognized in the International Classification of
Functioning, Disability and Health (ICF): body structure
and function (and impairment thereof), activity (and
activity restrictions) and participation (and participation
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restrictions) (3). The classification also recognizes the role
of physical and social environmental factors in affecting
disability outcomes. The ICF shifts the focus from the
cause of disability to its effect, thereby emphasizing
the role of the environment (physical, cultural, social,
political) rather than focusing on disability as a ‘medical’
or ‘biological’ dysfunction (3) (Appendix 1).
Leprosy is an important cause of preventable disability
(4). Physical impairment associated with leprosy is usually
secondary to nerve damage resulting from the chronic
granulomatous inflammation due to Mycobacterium
leprae (5). Impairments may give rise to disabilities, such
as limitations of activities involving the use of hands, feet
and eyes, and restrictions in social participation. The
World Health Organization (WHO) classifies leprosy-
related impairment into three grades: Grade 0  no
impairment, Grade 1  loss of sensation in the hand or
foot, and Grade 2  visible impairment (6). Multi-drug
treatment (MDT) can cure leprosy, and, if instituted early,
can prevent disability. However, leprosy is still often
diagnosed too late, when permanent impairment has
already occurred. Even after completion of treatment, a
significant proportion of patients sustain disability from
nerve damage, requiring continued (self-) care to limit
further secondary damage (5).
Future projections of the global leprosy burden show
that 5 million new cases would arise between 2000 and
2020, and that in 2020 there would be an estimated
1 million people with WHO grade 2 disability (7). There is
very little data on the types of problems faced by people
with leprosy-related disabilities (PLD) and the resulting
needs they have for services (5). The current ‘Enhanced
global strategy to further reduce the disease burden due to
leprosy’ of WHO describes the necessary elements of
prevention of disabilities and rehabilitation of persons
affected by leprosy. Though much progress has been made
in reducing the number of leprosy patients registered for
MDT globally, relatively little is known about disability
after release from treatment. Therefore there is an urgent
need for data on leprosy-related disability to assess the
need for prevention of disabilities (POD) and rehabilita-
tion services. Such data are also needed for programme
monitoring, evaluation and for advocacy (8).
In addition to physical impairments and activity
restrictions, PLD are likely to suffer from social stigma
and discrimination leading to economic loss (9). Accord-
ing to the ICF, social stigma and discrimination is
considered an important ‘environmental factor’ that
contributes to disability (3, 10, 11). Stigma is not a single
phenomenon, but consists of several possible components,
e.g. it may be conceptualized in terms of self-stigma (e.g.
shame and lowered self-esteem) or public stigma (e.g. the
general public’s prejudice) that is also associated with
social participation restrictions and discrimination (12,
13). The different aspects of health-related stigma can be
measured using questionnaires, qualitative methods, in-
dicators and scales (10). Similarly, suitable ICF-based
instruments now exist to assess different aspects of
disability and the factors contributing to these (5).
Indonesia ranks third in the number of new leprosy
cases after India and Brazil (14). We conducted a cross-
sectional baseline survey in five leprosy-endemic districts
in Indonesia. Our aim was to assess the extent of disability
and its determinants among persons with leprosy-related
disabilities after release from MDT. In particular, we
examined the incidence of worsening of physical impair-
ment after release from treatment, the impairment in
carrying out daily activities (activity restrictions), social
participation, stigma (anticipated) and discrimination, all
within the conceptual framework of the ICF.
Methods
Design and sampling
We conducted a cross-sectional house-to-house survey
amongst persons affected by leprosy in five districts in
Indonesia: Subang (West Java), Gresik, Malang (East
Java), Bone and Gowa (South Sulawesi). Eligible were
persons with any leprosy-related impairments, activity
limitations or participation restrictions who had been
released from MDT up to 5 years earlier. We obtained
lists from the district cohort registers of all people
affected by leprosy who had completed and been released
from treatment in the past 5 years. Local health workers
tried to contact as many of these as they could trace. The
persons contacted were asked for consent to be screened
for disability by leprosy-specialised health workers using
a short eight-question questionnaire (see Appendix 2).
Anyone answering ‘yes’ on any of the question was
eligible for inclusion and was invited to participate in the
study; all others were excluded. Furthermore, partici-
pants were excluded if they had mental impairment,
severe hearing or speaking problems or were aged less
than 10 years. Community members were selected
through convenience sampling in the communities where
persons affected by leprosy were contacted.
One hundred and twenty-six local leprosy workers
conducted a house-to-house survey between December
2008 and January 2009. All interviewers received exten-
sive and repeated training in conducting the interviews
and the use of the survey instruments. Closed question-
naires were administered as face-to-face interviews for all
subjects who consented to participate in the survey. We
obtained basic demographic data including age, gender,
marital status, employment status, WHO disability grad-
ing, and extent of physical impairment. Disability grading
was done according to the WHO Operational Guidelines
for the Enhanced Global Strategy 20112015 (15) and
consistently applied throughout the study. Where avail-
able we obtained the disability grades at diagnosis and
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RFT for all subjects enrolled in the survey from the
cohort register. In this way longitudinal data on physical
impairment were obtained for most subjects.
The rapid disability assessment (RDA) toolkit used
comprised generic methods and instruments for assessing
disability and stigma, compatible with the ICF conceptual
framework: Screening of Activity Limitation and Safety
Awareness (SALSA) scale, Participation Scale, Jacoby
Stigma Scale, Explanatory Model Interview Catalogue
(EMIC) stigma scale and Discrimination assessment form
(8, 10, 1623). Except for the discrimination question-
naire, all other instruments in the RDA toolkit were either
developed in or have been culturally validated in several
Asian countries in a similar target population. SALSA is a
20-item questionnaire that can be administered within
10 min and provides a standardized measure of limitations
in daily activities related to mobility, dexterity, self-care
and work (24). The Participation Scale is an 18-item
instrument to measure how respondents rate their parti-
cipation in comparison with a ‘peer’, defined as ‘someone
similar to the respondent in all aspects except for the
disease or disability’ (16). To measure anticipated stigma
(felt stigma) we used the three-item Jacoby Stigma Scale,
which measures the extent to which affected persons
perceive negative attitudes or behaviour of others as a
result of their condition (25). The Explanatory Model
Interview Catalogue (EMIC) has been developed to elicit
illness-related perceptions, beliefs, and practices (26). Part
of the EMIC is a stigma scale assessing community-
perceived stigma and discrimination related to a particu-
lar condition (19). We used a 15-item version adapted
from the original EMIC scale to assess perceived stigma
related to leprosy among the 931 community members
included in the survey. For recording discrimination
experiences, we used an adapted version of the leprosy
disability study form drafted by WHO-SEARO, which
assesses social discrimination experienced by people
affected by leprosy (see Appendix 3). All of the ques-
tionnaires were administered in the Indonesian language.
Oral consent was obtained from all adults and from
guardians of children. As this was operational research
carried out within the context of the routine leprosy
programme, the Leprosy Control Sub-Directorate of the
Ministry of Health did not consider it necessary to obtain
separate ethical approval.
Statistical analysis
Although 1,358 subjects were enrolled, not all were able
to complete all assessments at the time of the survey.
In addition, previous WHO disability grades were missing
for a number of subjects, particularly at RFT. For this
reason, we conducted one analysis on a cohort for whom
data was available on all 3 assessment occasions. Para-
metric statistical tests were used for ordinal variables.
Differences between percentages were tested using a z-test
for percentages. Non-parametric analysis of variance was
done using a Kruskal-Wallis test. Because the participa-
tion score was not normally distributed, multivariate
quantile regression was used to examine to joint effect
of a range of factors on the 75th quantile of the
participation score. The coefficients indicate by how
much the value of 75th quantile would be raised (or
lowered) for each unit change in the explanatory variable.
A higher value of the participation score indicated more
severe restrictions. All analyses were done with STATA
version 12.
Results
Of the 3,596 persons listed in the district cohort registers,
local health workers were able to contact 2,450 persons
(987 persons were unavailable due to migration, death or
untraceable address). Of these, 1,092 were excluded
because they did not have disability according to the
screening form, were aged less than 10, or had more severe
mental impairment or hearing or speaking problems;
1,358 persons were included in the survey (Fig. 1). The
demographic characteristics of our study sample are
presented in Table 1; 843 were male (63%); the mean age
was 42.5 years (range 290). The mean age for men was
40.6 (range 289) and for women it was 45.5 (range 290).
The proportion of persons who were separated, divorced
or widowed was higher among women (22.5%) than
among men (8.3%; pB0.001). The illiteracy rate was
31.9%. Men had better education than women, in terms
of completion of primary school, high school or advanced
high school (75.9% versus 54.8%, pB0.001). The propor-
tion of men who had salaried work was higher than of
women (69.6% versus 37.2%, pB0.001). Unpaid work,
including household work, was much more common
2,450 identified and 
assessed for eligibility 
3,596 people affected by 
leprosy listed  
1,146 migrated, 
died, untraceable 
1,092 without disability, 
aged less than 10 
years, having mental 
impairment, or hearing 
and speaking problems 
1,358 enrolled and 
interviewed: 
161 in Malang 
281 in Gresik 
357 in Subang 
236 in Gowa 
323 in Bone 
Fig. 1. Selection procedure of survey participants.
Disability in people affected by leprosy in Indonesia
Citation: Glob Health Action 2012, 5: 18394 - http://dx.doi.org/10.3402/gha.v5i0.18394 3
(page number not for citation purpose)
among women than among men (43.9% versus 14.6%; pB
0.001).
Table 2 shows that 76.7% of people had physical
impairment (48.7% grade 2 and 28.0% grade 1).
Figure 2 shows that most impairment was associated
with the feet (47%), followed by 31% associated with the
hands and 11% associated with eyes (grade 2). Table 3
shows that, before treatment with standard MDT, 31% of
the people already had grade 1 impairment and 31% had
grade 2 impairment. The impairment status did not
change significantly during treatment. At RFT, 27% had
grade 1 and 32% had grade 2 impairment. However,
25 years after RFT, 26% of the people had grade 1
impairment and 49% had grade 2 impairment. This
difference was statistically highly significant. Table 4
shows the progression of impairment grades between
diagnosis and the time of the survey. Among those with
grade 0 at diagnosis, 48% developed additional or worse
impairments; among those with grade 1, this percentage
was 32%. In total 26% of those with grade 1 or 2 at
diagnosis improved.
About 60% of the people had a limitation in executing
daily activities (Table 2). A similar percentage had
problems participating in social life and 35.5% expressed
that they experienced stigma (Table 2).
A profile of the EMIC stigma scale items (Fig. 3)
showed that the main stigma-related problems perceived
by the community were shame and embarrassment,
problems in finding a marriage partner and difficulties
in finding salaried work. These results were consistent
with the experiences of the affected persons shown in
Fig. 4. Prominent discrimination issues were problems
related to marriage, getting married and employment.
As shown in Table 5, participation was significantly
associated with age, education level, owning a motorbike,
number of wounds, activity level and anticipated stigma
(pB0.001), but not with gender. The 75th quantile of the
participation score was six points lower for those with
primary and eight points for those with higher education,
compared to people without formal schooling. Severe
activity limitations and/or the highest level of anticipated
stigma was associated with a much higher level participa-
tion restriction (13.8 and 20.8 points, respectively).
Table 1. Demographic characteristics of people affected
by leprosy with disability in five districts in Indonesia
(n1,339)
Variables
Male
n843 (%)*
Female
n496 (%)
Total
n1,339 (%)
Age (years) 40.6 (289) 45.5 (290)
Mean (range) 42.5 (290)
Marital status
Single 238 (28.2) 94 (19.0) 332 (24.8)
Married 535 (63.5) 290 (58.5) 825 (61.6)
Separated/
divorced/
widowed
70 (8.30) 112 (22.5) 182 (13.6)
Education
Illiterate 203 (24.1) 224 (45.2) 427 (31.9)
Primary school 397 (47.1) 191 (38.5) 588 (43.9)
High school/
advanced
243 (28.8) 81 (16.3) 324 (24.2)
Employment
Paid work 163 (19.4) 48 (9.7) 211 (15.8)
Self-employed 423 (50.2) 136 (27.5) 559 (41.8)
Unpaid work 123 (14.6) 217 (43.9) 340 (25.5)
Unemployed 133 (15.8) 93 (18.8) 226 (16.9)
*Column percentages.
Table 2. Disability components in people with leprosy-
related disability in the five-district study in Indonesia
Variables Male (%) Female (%) Total
WHO impairment grading (n1,327)
Grade 0 175 (21.3) 130 (26.8) 305 (23.3)
Grade 1 211 (25.7) 155 (31.8) 366 (28.0)
Grade 2 436 (53.0) 201 (41.4) 637 (48.7)
Activity limitation (n1,173)
None 333 (44.5) 147 (34.7) 480 (40.9)
Mild 219 (29.2) 144 (31.1) 363 (31.0)
Severe 197 (26.3) 133 (31.4) 330 (28.1)
Social participation (n1,338)
None 338 (40.1) 180 (36.3) 518 (38.7)
Mild 313 (37.2) 192 (38.7) 505 (37.7)
Moderate 108 (12.8) 79 (15.9) 187 (14.0)
Severe 83 (9.90) 45 (9.1) 128 (9.6)
Anticipated stigma (n1,340)
No 540 (64.2) 321 (64.9) 861 (64.5)
Yes 301 (35.8) 174 (35.1) 475 (35.5)
Fig. 2. Distribution of grade 0, 1 and 2 impairments after
release from treatment (RFT).
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Comparison of community stigma, anticipated stigma,
participation score and Salsa score by district (Table 6)
showed a relationship between the level of community
stigma and the level of participation reported by PLD.
Both were higher in Gresik, Bone and Gowa than in
Malang and Subang. These differences were statistically
significant (pB0.001, Kruskal Wallis test). This pattern
was not seen for PLD-anticipated stigma or activity level.
Discussion
Our findings show that people affected by leprosy
experience major problems in all four components of
disability, body functions and structures, activities and
participation, personal factors and environmental factors.
The majority of the subjects had leprosy-related physi-
cal impairments (75%). A substantial proportion (39%) of
those with visible impairments at the time of the survey
had developed these after release from treatment (RFT;
see Table 4). Other investigators also reported that
worsening of impairments was accelerated after RFT
compared to during treatment (27). They found a
significant association between impairment at diagnosis
and the risk of developing additional impairment after
RFT. The most important determinant for future impair-
ment was impairment status at diagnosis (27). This
finding indicates a need for specific activities to prevent
worsening of impairments also after RFT, especially
surveillance of persons at high risk, training in foot and
hand care, and provision of assistive devices.
Both felt (anticipated) stigma and community stigma
were high in our study population. Perception of stigma
and experiences of discrimination cause people to feel
ashamed, and may cause them to isolate themselves from
society, thus perpetuating the stereotype that leprosy is
something shameful to be hidden away (28). It may cause
anxiety, depression, isolation, problems in family relation-
ships and friendships and reduce treatment adherence and
chances of recovery (2931). As a consequence, stigma,
activity and participation are usually more important
to the affected person and their family than physical
impairment (32).
The proportion of people with participation restrictions
(about 60%) was much higher in this study than in studies
in China (46%) (33) and in India (34%), but was measured
in a sample who had screened positive for ‘any disability’.
When using social participation as the main outcome
measure, increasing levels of impairment and activity
limitation increased the risk of participation restrictions
significantly. Higher education and owning a motorcycle 
personal factors in the ICF model  had a protective
effect. The ‘motorcycle effect’ may either be explained as a
proxy for wealth or social status, or work more directly
through increasing mobility. Higher levels of anticipated
stigma, as a proxy for stigma as environmental factor,
were strongly associated with increased participation
restrictions. Similar findings have been reported studies
in Bangladesh, India and Brazil (34, 35). This shows that,
to improve social participation, interventions may be
needed at different levels. At the personal and physical
level this would include measures such as improving
education, income and activity, addressing physical im-
pairments and rehabilitation; and at the societal level,
reduction of stigma in the community and addressing
other environmental barriers.
Multivariate analysis confirmed the strong associations
between the different components of disability. The ICF
emphasizes the important role of the environment and
personal factors influencing body function, activities and
Table 3. Development of grade 1 and grade 2 impairments at diagnosis, at release from treatment and at the time of the survey
in a sub-cohort of people with leprosy-related disability who had assessment on all three occasions in the five-district study in
Indonesia (n966)
At diagnosis n (%^) At release from treatment n (%^) At survey n (%^)
Type Grade 0 Grade 1 Grade 2 Grade 0 Grade 1 Grade 2 Grade 0 Grade 1 Grade 2
PB 51 (64) 19 (24) 10 (13) 54 (68) 18 (23) 8 (10) 37 (46) 19 (24) 24 (30)*
MB 314 (35) 279 (31) 293 (33) 344 (39) 242 (27) 300 (34) 204 (23) 234 (26) 448 (51)**
Total 365 (38) 298 (31) 303 (31) 398 (41) 260 (27) 308 (32) 241 (25) 253 (26) 472 (49)**
^Row percentages; *Differences between percentage with grade 2 at diagnosis and at the survey; PB: p0.012; **MB and total:
pB0.0001.
Table 4. Changes in impairment grades between diagnosis
and the time of the survey in people with leprosy-related
disability who had assessment on both occasions in the
five-district study in Indonesia
Grade at
diagnosis
Grade at survey n (row%)
n 0 1 2
0 459 240 (52.3) 100 (21.8) 119 (25.9)
1 402 57 (14.2) 216 (53.7) 129 (32.1)
2 430 5 (1.2) 45 (10.5) 380 (88.4)
Total 1,291 302 (23.4) 361 (28.0) 628 (48.6)
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participation and thus as determinants of disability.
Especially stigma and discrimination are powerful forces
in society that profoundly affect the lives of millions of
people affected by stigmatized health conditions (36). Our
study showed that stigmatising attitudes related to shame
were most predominant, followed by problems to find a
marriage partner, problems in marriage and problems to
find work. Despite this, the majority of people interviewed
did not feel stigmatised by others. Reasons for this
discrepancy could be underreporting of perceived stigma
or insufficient sensitivity of the Jacoby stigma scale. The
high level of stigmatising attitudes in the community was
confirmed by the results of qualitative data (reported
elsewhere). It is possible, however, that these were not
enacted and, as a result, people affected did not actually
experience stigma very frequently. However, from the
demographic data we observed some possible implications
of disability or stigma due to leprosy. Thirty-eight percent
of the people affected were unmarried, divorced, sepa-
rated or widowed. This is significantly more than in a
community sample with a similar age-distribution (n
101) in a recent study in Indonesia (22%; to be published
elsewhere). It may be the effect of community stigma and
discrimination, since problems in marriage were reported
by the respondents as one of the major difficulties they
faced. This has been reported elsewhere also. A study in
South Africa showed that one-third of leprosy patients
were abandoned by their spouses (37). Our study showed
Fig. 3. Results of the Explanatory Model Interview Catalogue (EMIC) stigma scale.
Fig. 4. Examples for discrimination from the discrimination scale.
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that women were disproportionately affected by separa-
tion and divorce then men, which can possibly be
explained by the observation that women tend to be
more disempowered than men when actively choosing
partners and pursuing marriage. Social discrimination in
marital relationships should be addressed through coun-
selling and through advocacy in the community, with a
particular focus on the needs of women.
A substantial proportion of the people with leprosy-
related disability were unemployed or did unpaid work
(42%). Women were disproportionally affected by un-
employment, which may also be explained by the overall
status of employment in a society such as Indonesia, as
well as the reported lower educational status as seen in
this study. The observation of high unemployment rates
fits our findings regarding community stigma and the
results of the Participation Scale, both of which showed
that employment was one of the major problem areas.
People may lose their employment because of functional
disabilities associated with leprosy and or because of
negative attitudes of employers or the community. This
has a major impact on people’s economic ability to
support themselves and their families (38, 39). Being able
to make a financial contribution influences a person’s
status in his family and in the community. In the light of
these needs, socio-economic rehabilitation (SER), such as
income generating projects and vocational training,
should be given first priority. This will enable people
affected by leprosy to find productive employment,
contribute to the economy of their family and live with
dignity. In a study in Nigeria, SER not only resulted in
improved self-esteem, skills acquisition and financial
independence, but also seemed to have initiated positive
change processes in the norms and values of social
interaction with people affected by leprosy (29).
Our study underlines that people with disability are
often burdened with social stigma that promotes a cycle
of poverty via unemployment, social discrimination and
threats to mental health (12). The findings of our survey
show that stigma reduction activities and socio-economic
rehabilitation are urgently needed in addition to strate-
gies to reduce the development of further physical
impairment after release from treatment.
Conclusion
This survey adds further evidence about the extent of
disability that many persons affected by leprosy still have
to cope with after completion of treatment. We showed
that persons affected by leprosy face a substantial risk of
Table 5. Factors associated with participation restriction in
people with leprosy-related disability in the five-district study
in Indonesia (n1,164)
Participation score
Factors Adjusted coefficients (95% CI)* p-value
Sex NS**
Age 0.15 (0.24 to 0.072) B0.0001
Education
Illiterate/non-formal Baseline
Primary 6.5 (9.2 to 3.7) B0.0001
High school/
advanced
8.3 (12.0 to 4.7) B0.0001
Owning a motorbike
No Baseline
Yes 2.7 (5.1 to 0.32) 0.026
Activity limitation
None Baseline
Mild 4.5 (1.87.2) 0.001
Severe 14.5 (11.617.5) B0.0001
Anticipated stigma score
0 Baseline
1 7.7 (4.510.9) B0.001
2 10.4 (6.314.4) B0.001
3 20.9 (17.324.5) B0.001
*Adjusted coefficient and their 95% confidence intervals and
p-values were obtained using quantile regression on the 75th
quantile; **NSNot Significant (p0.05)
Table 6. The median scores of community stigma, anticipated stigma, activity limitation and participation restriction among
community members and persons with leprosy-related disabilities in the five-district study in Indonesia
Median scores
Districts
Community stigma score
(n1,072)
Anticipated stigma score
(n1,340)
Activity score
(n1,175)
Participation score
(n1,342)
Subang 13 0 26 7
Malang 13 0 26 7
Gresik 15 1 27 13
Bone 16 0 29 10
Gowa 16 0 26 11
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deteriorating impairments after they are released from
treatment with MDT. They often ‘disappear off the public
health radar’. Women, in particular, suffer from the
consequences of discrimination and stigma, as shown
by higher unemployment and divorce rates. Depending
on their situation, many will need appropriate support,
training in self-care, monitoring of impairment status and
rehabilitation. In addition to physical impairment, the
stigma of leprosy has a large impact on many people’s
lives, affecting their physical, psychological, social and
economic well-being. Stigma has multiple causes; these
should be addressed in partnership with communities and
persons affected. Stigma reduction activities and socio-
economic rehabilitation are urgently needed in addition
to strategies to reduce the development of further dis-
abilities after release from treatment.
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Appendix 1
International classification of functioning, disability and health (ICF), modified from the World Health Organization (3).
Appendix 2
Screening questionnaire used in the five-district survey in Indonesia to screen for the presence of any difficulties in
functioning.
Appendix 3
Discrimination questionnaire
Please answer the following questions:
1. Have you ever been at school? Yes No
a. If NO, ask: why not? Have you ever not been admitted to school or other education because being affected by
leprosy? Yes No
b. If YES, ask: Have you ever been forced to leave or removed from school/other education because being affected by
leprosy? Yes No
2. Have you ever been married? Yes No
a. If NO, ask: Why not? Have you ever been not able to marry because being affected by leprosy? Yes No
b. If YES, ask: Have you ever been left or separated/divorced by your spouse because being affected by
leprosy? Yes No
Yes No
1. Do you have difficulty with seeing, even when wearing glasses?
2. Do you have difficulty walking or climbing steps?
3. Do you have difficulty washing all over or dressing?
4. Are there activities that you cannot perform?
5. Do you have loss of feeling in the hands and/or feet?
6. Do you have any weakness in hands and/or feet?
7. Do you have any wounds on hands and/or feet?
8. Do you have any problems in relationships or in taking part in festivities, work, meetings, etc?
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3. Have you ever been working? Yes No
a. If No, ask:
- Why not? Have you ever been refused employment because being affected by leprosy? Yes No
- Have you ever been restricted or banned in your employment for certain areas e.g. as cook or domestic helper because
being affected by leprosy? Yes No
b. If YES, ask:
- Have you ever been forced to leave or removed from a job because being affected by leprosy? Yes No
- Has your promotion ever been negatively affected because being affected by leprosy? Yes No
4. Did you ever use public transportation? Yes No
If NOT, continue with question No 5
If YES, ask: Have you ever been refused travel by public transport because being affected by leprosy? Yes No
5. Have you ever been at places of worship (temple, church, mosque or other)? Yes No
If NOT, continue with question No 6
If YES, ask: Have you ever been refused admission into a temple, church, mosque or other places of worship because
being affected by leprosy? Yes No
6. Have you ever been to public places like shops or restaurants? Yes No
If NOT, continue with question No 7
If YES, ask: Have you ever been refused admission into a restaurant, hotel, shops etc because being affected by
leprosy? Yes No
7. Have you ever been seeking medical care in a hospital or a health centre or at a doctor’s praxis? Yes No
If NOT, continue with question No 8
If YES, ask: Have you ever been refused medical care or hospital/clinic admission because being affected by
leprosy? Yes No
8. Are you old enough to vote or be voted? Yes No
If NOT, continue with question No 9
If YES, ask: Have you ever been banned from standing for elections or refused to vote because being affected by
leprosy? Yes No
9. Have you ever experienced other discriminatory situations? Yes No
If YES, can you please explain?
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